Maglie (LE)
Life Science
Bio Aurum
Bio Aurum spearheads the medical research and development of nature-based treatments for a range of neurodegenerative diseases. The initial focus is on exploiting the naturally occurring bioactive molecules of saffron believed to target defined pathogenic pathways in Alzheimer’s and Parkinson’s diseases. Pipeline development is ICH-compliant and based on proprietary technology.
Bio Aurum combines a scientific approach with stringent clinical validation to advance medicine and improve health through nature.